Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is a synthetic imidazole antifungal agent. It is available as a vaginal pessary for the treatment of vulvovaginal candidiasis.
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **100 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 7 consecutive nights.
* **200 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 3 consecutive nights.
* **100 mg vaginal suppository (may be used interchangeably with pessary):** Insert 1 suppository vaginally at bedtime for 7 consecutive nights.
## Pediatric Dosing
Use in pediatric patients is generally not recommended due to limited safety and efficacy data. Consult with a pediatrician or infectious disease specialist for guidance.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment with vaginal administration.
## Contraindications
* Known hypersensitivity to miconazole or any component of the formulation.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation, redness, pelvic cramps.
* **Less Common:** Headache, rash.
## Key Drug Interactions
* **CYP3A4 Inhibitors:** Miconazole is a potent inhibitor of CYP3A4. Concurrent use with oral midazolam or triazolam can lead to exaggerated and prolonged sedative effects. Avoid coadministration. If coadministration is unavoidable, monitor closely for CNS depression.
* **Warfarin:** Miconazole may increase the anticoagulant effect of warfarin. Monitor INR closely, especially if higher doses or prolonged treatment are used. Dose adjustment of warfarin may be necessary.
## Monitoring
* Monitor for signs and symptoms of vulvovaginal candidiasis to assess treatment efficacy.
* Monitor for signs of local irritation or allergic reaction.
## Clinical Pearls
* Complete the full course of therapy even if symptoms improve earlier.
* Avoid sexual intercourse during treatment to prevent potential reinfection and to avoid irritation from the pessary.
* Pessaries may weaken latex condoms and diaphragms, rendering them less effective. Advise patients to use alternative methods of contraception during treatment and for at least 72 hours after completing therapy.
* If symptoms persist after completing treatment, or if they worsen, re-evaluate for alternative diagnoses or resistant organisms.
***
**Disclaimer:** This information is intended for clinical use by healthcare professionals. It is not exhaustive and does not replace professional medical advice. Always consult the most current prescribing information and relevant guidelines before making treatment decisions.
